Appropriate Use of Drug Testing in Clinical Addiction Medicine Consensus Document
The purpose of the Appropriate Use of Drug Testing in Clinical Addiction Medicine is to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addictionDownload
About the Document
Drug testing uses a biological sample to detect the presence or absence of a specific drug (or drugs) as well as drug metabolites within a specific window of time. No universal standard exists today in clinical drug testing for addiction identification, diagnosis, treatment, medication monitoring, or recovery.
The American Society of Addiction Medicine (ASAM) recognizes that the absence of guidance creates a vacuum. Even in the context of limited research about how to approach a given clinical practice, providers and payers make decisions about what kind of care patients should and do receive. This appropriateness document is intended to guide provider decisions about drug testing to improve the quality of care that patients with addiction receive
The Journal of Addiction Medicine features an article on the Appropriate Use of Drug Testing in Clinical Addiction Medicine that describes the rationale and process for creating this document, and summarizes the recommendations.
A quick reference tools for healthcare providers with instant access to key information of the document in a clear and concise format.
ASAM is offering a series of continuing medical education (CME) webinars on the consensus document.
A PowerPoint presentation on the consensus document with notes from the speaker.
Educational and promotional images that illustrate key points in the consensus document as well as notable data regarding addiction today.
Tools, messages and banners to promote the consensus document to your publics.